The U.S. Government Response to Biothreats and Emerging Infectious Diseases (Video)

event_image

Event Details

Date:
Thursday, February 5, 2015
6:30 PM - 7:30 PM 
Location:
PwC
300 Madison Avenue
New York, NY
Event type
Lecture / Panel  

Event Description

 

Please join the Foreign Policy Association for a talk with DrRobin Robinson, Director of the Biomedical Advanced Research and Development Authority and Deputy Assistant Secretary for Preparedness & Response, Department of Health and Human Services.

Mobilizing new assets and infrastructure for development and manufacturing of biothreat MCMs has enabled more rapid and stronger responses to recent emerging outbreaks including H7N9 outbreaks in China last year and the current Ebola epidemic in Africa this year.Dr. Robinson will explore these new assets and infrastructure and what stronger responses mean for the general American public. Dr. Robinson will discuss the results of the recent Ebola vaccine trials.

Dr. Robinson will be speaking as part of the Dame Jillian Sackler Distinguished Lecture Series on Global Health.

Event Speakers

    • Dr. Robin Robinson
      Director of the Biomedical Advanced Research and Development Authority and Deputy Assistant Secretary for Preparedness & Response U.S. Department of Health and Human Services

      In April 2008, Dr. Robin Robinson was appointed head of the Biomedical Research and Development Authority (BARDA) and Deputy Assistant Secretary in the Office of the Assistant Secretary for Preparedness and Response within HHS by the Pandemic and All-Hazard Preparedness Act of 2006. He also led the nation’s effort to develop and manufacture the largest amount of vaccine in U.S. History in response to the 2009 H1N1 pandemic. For his leadership in this role, Dr. Robinson was the recipient of the Department of Defense’s Clay Dalrymple Award in 2008 and a finalist for the Service to America Medal in 2009. Dr. Robinson received a Bachelor’s degree in Biology from Millsaps College in 1976, a Doctoral degree from the University of Mississippi Medical School in medical microbiology in 1981 with a dissertation on herpesvirus oncogenesis, and completed in 1983 a NIH postdoctoral fellowship with the State University of New York at Stony Brook in molecular oncology. Dr. Robinson also serves on the World Health Organization (WHO) international expert teams on Pandemic influenza vaccines.